David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$345M |
| 2 |
Biogen
BIIB
|
+$281M |
| 3 |
Bausch Health
BHC
|
+$244M |
| 4 |
SPDR Gold Trust
GLD
|
+$238M |
| 5 |
Coca-Cola
KO
|
+$206M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$397M |
| 2 |
AGN
Allergan Inc
AGN
|
+$374M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$347M |
| 4 |
Microsoft
MSFT
|
+$265M |
| 5 |
IBM
IBM
|
+$251M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 10.34% |
| 2 | Technology | 9.79% |
| 3 | Consumer Discretionary | 9.73% |
| 4 | Healthcare | 8.68% |
| 5 | Financials | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Allegion
ALLE
$13.8B
| $113M | 0.17% |
1,846,222
-216,833
| -11% | -$12.4M |
|
127
Ulta Beauty
ULTA
$22.4B
| $111M | 0.17% |
738,154
+52,470
| +8% | +$7.26M |
|
128
Carnival Corporation Ltd
CCL
$35.2B
| $111M | 0.17% |
2,317,669
+1,974,451
| +575% | +$88.9M |
|
129
Armstrong World Industries
AWI
$7.55B
| $111M | 0.17% |
1,923,612
+317,147
| +20% | +$17M |
|
|
LVLT
130
DELISTED
Level 3 Communications Inc
LVLT
| $110M | 0.17% |
2,039,636
+1,838,384
| +913% | +$95.8M |
|
131
NCR Voyix
VYX
$1.09B
| $109M | 0.17% |
6,037,098
+1,641,933
| +37% | +$28.5M |
|
|
TWX
132
DELISTED
Time Warner Inc
TWX
| $108M | 0.17% |
1,275,730
+340,796
| +36% | +$28.3M |
|
133
Tyson Foods
TSN
$20.6B
| $107M | 0.16% |
2,795,509
+653,295
| +30% | +$26.1M |
|
134
PUT
Amazon
AMZN
$2.79T
| $107M | 0.16% |
5,742,000
-9,532,000
| -62% | -$168M |
|
135
Teva Pharmaceuticals
TEVA
$43.5B
| $107M | 0.16% |
1,712,161
+382,351
| +29% | +$22.2M |
|
136
CSX Corp
CSX
$95.6B
| $107M | 0.16% |
9,660,906
+7,564,158
| +361% | +$87M |
|
|
KS
137
DELISTED
KapStone Paper and Pack Corp.
KS
| $107M | 0.16% |
3,245,798
-179,202
| -5% | -$5.7M |
|
|
OPLN
138
Openlane
OPLN
$4.08B
| $105M | 0.16% |
7,293,368
+1,091,619
| +18% | +$14.8M |
|
|
SNDK
139
DELISTED
SANDISK CORP
SNDK
| $105M | 0.16% |
1,644,340
+888,759
| +118% | +$72.2M |
|
140
CALL
Netflix
NFLX
$331B
| $104M | 0.16% |
17,472,000
-12,411,000
| -42% | -$75.3M |
|
141
American Express
AXP
$227B
| $103M | 0.16% |
1,322,795
+1,218,169
| +1,164% | +$101M |
|
|
CIT
142
DELISTED
CIT Group Inc.
CIT
| $103M | 0.16% |
2,276,678
-495,345
| -18% | -$22.5M |
|
143
Packaging Corp of America
PKG
$22.5B
| $101M | 0.16% |
1,296,762
-178,238
| -12% | -$14.1M |
|
144
SLB Ltd
SLB
$79.9B
| $101M | 0.16% |
1,214,750
+610,759
| +101% | +$50.8M |
|
145
Equity Lifestyle Properties
ELS
$12.7B
| $101M | 0.15% |
3,664,504
+22,220
| +0.6% | +$609K |
|
146
Amgen
AMGN
$238B
| $101M | 0.15% |
629,572
-297,067
| -32% | -$46.8M |
|
147
General Motors
GM
$77.2B
| $99.7M | 0.15% |
2,658,158
-407,066
| -13% | -$14.8M |
|
148
MGM Resorts International
MGM
$11B
| $99.2M | 0.15% |
4,716,743
-231,042
| -5% | -$4.84M |
|
149
Boston Scientific
BSX
$73B
| $99.1M | 0.15% |
5,582,326
-2,370,829
| -30% | -$37.5M |
|
150
PepsiCo
PEP
$196B
| $98.6M | 0.15% |
1,031,517
-1,505,837
| -59% | -$146M |
|
Similar funds
David Shaw's Q1 2015 Portfolio in Review
As of Q1 2015, David Shaw held 4,408 positions worth $65.3B, down 16% from $77.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $15B in Q1 2015, closing 828 positions and reducing 1,784 holdings. Its most notable exit was Allergan Inc, an estimated $374M position sold in full.
By sector, the portfolio is most concentrated in Energy at 10% of assets, up from 8.6% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in SPDR Gold Trust worth $231M.
- David Shaw's largest Q1 2015 buy was SPDR Gold Trust: 2,033,000 shares worth $231M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q1 2015, an estimated $345M increase.
- David Shaw's biggest Q1 2015 reduction was LyondellBasell Industries, cutting an estimated $397M.
- David Shaw fully exited Allergan Inc in Q1 2015, selling an estimated $374M.
- David Shaw's ten largest holdings make up 11% of its $65.3B portfolio in Q1 2015.
- David Shaw opened 448 new positions and closed 828 in Q1 2015.
- David Shaw's portfolio value fell 16% quarter-over-quarter to $65.3B.
Based on D.E. Shaw & Co's 13F filing for Q1 2015, filed 15 May 2015.